.png?sfvrsn=1e7191c0_3)
tirzepatide for menopause weight gain GLP-1s, Obesity, and Menopause: Benefits and Risks HRT and Tirzepatide: The Key
Description
Tirzepatide , originally developed for type 2 diabetes, works as a dual agonist targeting the GIP and GLP-1 receptors, both of which are integral to appetite control, insulin regulation, and energy balancekey factors in effective weight management
Is tirzepatide the same as Mounjaro or Zepbound
*In 68- and 72-week clinical trials, Tirzepatide was evaluated in patients without diabetes who had a BMI of 30 or a BMI of 27 with a weight-related condition
Always confirm benefits and potential reimbursement options directly with your insurer
